2025 C-Reactive Protein Testing Industry Trends Report: Long-Term Outlook Through 2034

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Large Will the C-Reactive Protein Testing Market Size By 2025?
In recent times, the market size for c-reactive protein testing has experienced a consistent growth. It is predicted to rise from $3.45 billion in 2024 to $3.55 billion in 2025, reflecting a compound annual growth rate (CAGR) of 2.9%. The escalation experienced in the historic phase can be ascribed to an upsurge in inflammatory disease instances, cardiovascular risk evaluation, a rise in the elderly population, enhanced healTH*Care facilities, and routine health screening programs.

How Big Is the C-Reactive Protein Testing Market Size Expected to Grow by 2029?
Expectations are high for the c-reactive protein testing market, with a strong surge in growth anticipated in the coming years. This market is predicted to reach $4.35 billion by 2029, displaying a compound annual growth rate (CAGR) of 5.2%. The growth during this forecast period is largely attributed to factors such as increasing obesity rates, the rise of personalized medicine and biomarkers, the expansion of telehealth and remote monitoring, early detection of diseases, and inflammation related to lifestyle. The forecast period is also expected to witness major market trends such as advancements in diagnostic testing, the rise in wearable health technology, innovative technological solutions, strategic partnerships, and the advent of the industry 4.0.

View the full report here:
https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

Which Key Market Drivers Powering C-Reactive Protein Testing Market Expansion and Growth?
The escalation in cardiovascular disease (CVD) cases is anticipated to drive the expansion of the c-reactive protein testing market. CVDs encompass heart conditions like diseased vessels, structural issues, and blood clot formations. The precise cause of CVD remains unknown, yet several factors can elevate its development risk. Behavioural risks - such as imbalanced diet, inactive lifestyle, smoking, and alcohol intake - can cause an accumulation of fatty residues within the arteries (atherosclerosis), consequently raising the risk of blood clots. These lifestyle risks lead to increased blood pressure, blood sugar levels, blood lipids, weight, and obesity. The growing number of cardiovascular disease cases underscores the necessity for c-reactive protein testing as a diagnostic or predictive tool for cardiovascular complications comparably effective as cholesterol levels. In December 2023, for example, the Institute for Health Metrics and Evaluation reported that global fatalities due to cardiovascular diseases reached 19.8 million in 2022, with ischemic heart disease causing the highest death rate of 108.8 per 100,000 people. High systolic blood pressure was the primary contributor to disability-adjusted life years (DALYs) related to CVD, while diet-related risks and air pollution were the significant behavioural and environmental drivers of this global health burden.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6719&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the C-Reactive Protein Testing Market?
The upward trend in technological advancements pertaining to measuring instruments is a significant factor in the c-reactive protein testing market. Major companies in the market are keen on delivering cutting-edge solutions to consolidate their market standing. Adopting the latest c-reactive testing technologies for their testing methods and offering solutions that ensure maximum output and multiple applications are the ways they are doing so. For example, Aidian, a Finnish firm specializing in diagnostic tests and test solutions, launched the QuikRead go wrCRP & wrCRP+Hb kits in February 2022. These kits consistently give two outcomes, a broad spectrum of CRP and Hb, from a single sample through one analysis. The broad-spectrum CRP test allows for CRP readings to evaluate conditions like neonatal sepsis, foresee the severity of conditions like chronic obstructive pulmonary disease (COPD), and facilitate cardiovascular risk assessment.

What Are the Emerging Segments in the C-Reactive Protein Testing Market?
The c-reactive protein testing market covered in this report is segmented -

1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays
2) By Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications
3) By End Use: Clinics, Hospitals, Diagnostic Laboratories

Subsegments:
1) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA, Indirect ELISA, Sandwich ELISA
2) By Chemiluminescence Immunoassay (CLIA): Luminometer-Based CLIA, Automated CLIA Systems
3) By Immunoturbidimetric Assays: Nephelometry-Based Immunoturbidimetric Assays, Latex Agglutination Immunoturbidimetric Assays

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=6719&type=smp

Who Are the Global Leaders in the C-Reactive Protein Testing Market?
Major companies operating in the c-reactive protein testing market include Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG, Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation, Tosoh Corporation, Trinity Biotech Plc, WerfenLife Group LLC, ZEUS Scientific Inc., BioMérieux SA, Biomerica Inc., Gold Standard Diagnostics Corp., Immunodiagnostic Systems Holdings PLC, Nova Biomedical Corporation

Which are the Top Profitable Regional Markets for the C-Reactive Protein Testing Industry?
North America was the largest region in the c-reactive protein testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the c-reactive protein testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6719

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.